We tested autoantibodies to neurofascin-186 (NF186) and gliomedin in sera from patients with multifocal motor neuropathy (MMN, n=53) and chronic inflammatory demyelinating polyneuropathy (CIDP, n=95) by ELISA. IgG antibodies to NF186 or gliomedin were found in 62% of MMN and 1% of CIDP sera, and IgM antibodies to the same antigens in 12% of MMN and 1% of CIDP sera. These autoantibodies activated complement. Ten percent of the MMN sera without IgM anti-GM1 reactivity had anti-NF186 antibodies. Because NF186 and gliomedin play a crucial role for salutatory conduction, the autoantibodies may contribute to produce motor nerve conduction block and muscle weakness in MMN.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jneuroim.2014.09.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anti-neurofascin autoantibody and demyelination.
Neurochem Int
November 2019
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Article Synopsis
- Demyelination diseases in both the central and peripheral nervous systems are caused by various immune responses, including cell-mediated and humoral immunity, with new research identifying specific autoantibodies against nodal and paranodal proteins as contributors to conditions like multiple sclerosis and Guillain-Barré syndrome.
- These autoantibodies, particularly the IgG4 subclass, are associated with unique disease features and collectively categorized as nodopathy or paranodopathy, which can complicate diagnosis and treatment since these conditions often resist standard immunotherapies.
- The role of IgG4 autoantibodies appears to disrupt critical protein interactions necessary for nerve function, leading to conduction failures, but further research is needed to understand the specific manifestations of IgG4 autoant
Glial M6B stabilizes the axonal membrane at peripheral nodes of Ranvier.
Glia
April 2018
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Glycoprotein M6B and the closely related proteolipid protein regulate oligodendrocyte myelination in the central nervous system, but their role in the peripheral nervous system is less clear. Here we report that M6B is located at nodes of Ranvier in peripheral nerves where it stabilizes the nodal axolemma. We show that M6B is co-localized and associates with gliomedin at Schwann cell microvilli that are attached to the nodes.
View Article and Find Full Text PDFMutations in GLDN, Encoding Gliomedin, a Critical Component of the Nodes of Ranvier, Are Responsible for Lethal Arthrogryposis.
Am J Hum Genet
October 2016
INSERM UMR-1169, Université Paris Saclay, Le Kremlin Bicêtre 94276, France. Electronic address:
Article Synopsis
- Arthrogryposis multiplex congenita (AMC) is a condition marked by joint contractures due to reduced fetal movements.
- Researchers found biallelic mutations in the GLDN gene, which affects gliomedin, in families with lethal AMC, impacting nerve development.
- The mutations disrupt gliomedin’s function and its interaction with neurofascin-186, leading to impaired node formation essential for proper nerve signaling, highlighting a new category of inherited nerve disorders.
[New insights on the organization of the nodes of Ranvier].
Rev Neurol (Paris)
December 2014
Centre de recherche en neurobiologie et neurophysiologie de Marseille, faculté de médecine secteur Nord, Aix-Marseille université, CNRS-UMR7286, 51, boulevard Pierre-Dramard, CS80011, 13344 Marseille cedex 15, France. Electronic address:
Myelin plays a crucial role in the rapid and saltatory conduction of the nerve impulse along myelinated axons. In addition, myelin closely regulates the organization of the axonal compartments. This organization involves several complex mechanisms including axo-glial contact, diffusion barriers, the cytoskeletal network, and the extracellular matrix.
View Article and Find Full Text PDFAutoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
J Neuroimmunol
November 2014
Department of Neuroscience and Imaging, University "G. d'Annunzio", Chieti-Pescara, Italy.
We tested autoantibodies to neurofascin-186 (NF186) and gliomedin in sera from patients with multifocal motor neuropathy (MMN, n=53) and chronic inflammatory demyelinating polyneuropathy (CIDP, n=95) by ELISA. IgG antibodies to NF186 or gliomedin were found in 62% of MMN and 1% of CIDP sera, and IgM antibodies to the same antigens in 12% of MMN and 1% of CIDP sera. These autoantibodies activated complement.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!